BPC-157 (500mcg) 30 Tablets

What is BPC-157 (500mcg) x 30 tablets x 30 tablets?

BPC-157 (500mcg) x 30 tablets is a synthetic pentadecapeptide made up of 15 amino acids. It is derived from a protein fragment originally found in human gastric juice and has been synthesized for use in laboratory research. This compound is commonly categorized as a regenerative and tissue-research peptide.

Identification

• Chemical Formula: C₆₂H₉₈N₁₆O₂₂
• Molecular Weight: 1419.5 g/mol
• Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

BPC-157 (500mcg) x 30 tablets is produced as a research-grade material, typically manufactured to high purity standards (≥95% by HPLC verification). It has been studied in preclinical models for its potential involvement in tissue integrity, vascular response, and cellular repair mechanisms. All studies remain experimental.

What are the key features of BPC-157 (500mcg) x 30 tablets?

BPC-157 (500mcg) x 30 tablets is supplied in a research-grade format suitable for controlled laboratory environments. Key features include:

• High research-grade purity (≥95% typical analytical standard)
• Studied in tissue repair and angiogenesis research models
• For laboratory research use only

This material is intended strictly for in vitro and preclinical investigations.

How is BPC-157 (500mcg) x 30 tablets synthesized?

BPC-157 (500mcg) x 30 tablets is synthesized using solid-phase peptide synthesis (SPPS), a standard laboratory method for assembling short peptide chains. The 15-amino acid sequence is constructed step-by-step, allowing for precise control over the peptide's structure and composition. After synthesis, the peptide is purified using high-performance liquid chromatography (HPLC), and its identity and molecular mass are typically confirmed using mass spectrometry (MS). The final product is lyophilized to enhance its stability during storage and transport in research settings.

What is BPC-157 (500mcg) x 30 tablets being studied for? What are its possible benefits?

BPC-157 (500mcg) x 30 tablets has been studied in preclinical models focusing on connective tissue repair and vascular biology. Research has explored its potential role in:

• Angiogenesis (formation of new blood vessels)
• Muscle and tendon injury models
• Gastrointestinal mucosal research
• Ligament and soft tissue studies

In laboratory settings, BPC-157 has been investigated for its possible effects on cellular migration, extracellular matrix stability, and vascular growth signaling. These potential biological effects remain under investigation and are based on controlled experimental findings, not clinical outcomes.

How does BPC-157 (500mcg) x 30 tablets work in research studies?

In experimental models, BPC-157 (500mcg) x 30 tablets is being explored for its interaction with signaling pathways involved in tissue repair and vascular function. Early studies suggest that it may influence growth factor activity and cellular communication processes that help maintain the integrity of structural tissues. Researchers believe BPC-157 can modulate processes that affect blood vessel formation, inflammation signaling, and extracellular matrix regulation in laboratory models. These mechanisms are still being studied in controlled environments and do not establish clinical use.

What dosing information exists for BPC-157 (500mcg) x 30 tablets?

Preclinical studies of BPC-157 have been conducted primarily in animal and cell culture models. In murine (mouse) research, the peptide has been studied at doses ranging from approximately 10 µg/kg to higher microgram or milligram per kilogram (mg/kg) levels, depending on the experimental design. In vitro (cell culture) studies often use nanomolar to micromolar concentrations to evaluate cellular responses. Dosing protocols can vary widely based on research objectives, tissue models, and exposure duration. There are no established human dosing guidelines for BPC-157 (500mcg) x 30 tablets, as it is intended exclusively for laboratory research.

How should BPC-157 (500mcg) x 30 tablets be stored and handled?

BPC-157 (500mcg) tablets should be stored at controlled room temperature in a cool, dry environment. Keep the product in its original container or sealed packaging to protect it from moisture, humidity, and direct light, which may affect its stability. Refrigeration is generally not required for tablet formulations. However, storage at 2–8 °C may be used in controlled research environments if recommended by the laboratory protocol. The tablets should not be exposed to excessive heat or high humidity. Under proper storage conditions, BPC-157 (500mcg) tablets typically remain stable for up to 24 months. Standard laboratory handling procedures, including the use of appropriate protective equipment and proper documentation, should be followed in research settings.

Where can I read more research about BPC-157 (500mcg) x 30 tablets?

The following peer-reviewed publications provide background information on BPC-157 research:

1. National Center for Biotechnology Information. PubChem Compound Summary for CID 9941957, Bpc-157. https://pubchem.ncbi.nlm.nih.gov/compound/Bpc-157
2. He L, Feng D, Guo H, et al. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Front Pharmacol. 2022;13:1026182. Published 2022 Dec 14. doi:10.3389/fphar.2022.1026182
3. Xu C, Sun L, Ren F, et al. Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds. Regul Toxicol Pharmacol. 2020;114:104665. doi:10.1016/j.yrtph.2020.104665
4. Sikiric P, Seiwerth S, Rucman R, et al. Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157. Curr Med Chem. 2012;19(1):126-132. doi:10.2174/092986712803414015
5. Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612-1632. doi:10.2174/138161211796196954

Compliance Statement

This product is intended for laboratory research use only and is not approved for human or veterinary use.